果蝇Zeste基因增强子人类同源物2(Drosophila zeste gene enhancer of human homolog 2,EZH2)是一种参与基因负性表观遗传调控的甲基转移酶。研究发现,EZH2在多种肿瘤组织中高表达,并与肿瘤的发生发展和侵袭转移密切相关,由此成为抗肿瘤治疗新的分子靶点。目前已研发出多种EZH2抑制剂用于肿瘤的基础和临床治疗研究,并取得令人鼓舞的结果。本文将对EZH2小分子抑制剂的研究进展做简要综述。
The Drosophila zeste gene enhancer of human homolog 2(EZH2) is a methyl-transferase which involves in the negatively epigenetic regulation of gene expression.It is found that EZH2 is highly expressed in various tumor tissues and closely related to tumorigenesis,invasion and metastasis,thus become a new molecular target for the tumor therapy.Multiple EZH2 inhibitors have been developed and used in the basic and clinical tumor studies,from which the encouraging results have been obtained.This article has reviewed the research progress of small molecule inhibitors of EZH2.